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Abstract  42 
Introduction 43 
It is widely debated whether fetal membranes possess a genuine microbiome, and if 44 
bacterial presence and load is linked to inflammation. Chorioamnionitis is an inflammation 45 
of the fetal membranes. This research focussed on inflammatory diagnosed histological 46 
chorioamnionitis (HCA) and aims to determine whether the bacterial load in fetal 47 
membranes correlates to inflammatory response, including histological staging and 48 
inflammatory markers in HCA. 49 
Methods  50 
Fetal membrane samples were collected from patients with preterm spontaneous labour 51 
and histologically phenotyped chorioamnionitis (HCA; n=12), or preterm (n=6) and term 52 
labour without HCA (n=6). The bacterial profile of fetal membranes was analysed by 53 
sequencing the V4 region of the 16S rRNA gene. Bacterial load was determined using qPCR 54 
copy number/mg of tissue. The association between bacterial load and bacterial profile 55 
composition was assessed using correlation analysis. 56 
Results 57 
Bacterial load was significantly greater within HCA amnion (p=0.002) and chorion (p=0.042), 58 
compared to preterm birth without HCA. Increased bacterial load was positively correlated 59 
with increased histological staging (p=0.001) and the expression of five inflammatory 60 
markers; IL8, TLR1, TLR2, LY96 and IRAK2 (p=<0.050). Bacterial profiles were significantly 61 
different between membranes with and without HCA in amnion (p=0.012) and chorion 62 
(p=0.001), but no differences between specific genera were detected. 63 
Discussion 64 
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Inflammatory HCA is associated with infection and increased bacterial load in a dose 65 
response relationship. Bacterial load is positively correlated with HCA severity and the TLR 66 
signalling pathway. Further research should investigate the bacterial load threshold required 67 
to generate an inflammatory response in HCA. 68 
 69 
Short title: Fetal membrane bacterial load is increased in HCA  70 
Highlights:  71 
- Increased bacterial load was significantly associated with inflammation 72 
- Bacterial load is correlated with HCA severity in a dose dependent manner 73 
- Bacterial load is correlated to the TLR signalling pathway 74 
- Non-HCA samples and negative controls are not distinct in bacterial load. 75 
 76 
Keywords: Histological chorioamnionitis; Placenta; Fetal membrane; Microbiome; 77 
Inflammation; Bacterial load.  78 
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Introduction  79 
Histological chorioamnionitis (HCA) is an inflammation of the fetal membranes [1], linked to 80 
adverse maternal and neonatal outcomes, including preterm birth [2], early onset sepsis and 81 
necrotising enterocolitis [3,4]. HCA incident rates are higher in preterm (15%) compared to 82 
term (5%) infants [5]. 83 
The origin of bacteria within the healthy fetal membrane microbiome is widely debated [6]. 84 
Conflicting studies have suggested that the placenta and fetal membranes are: (i) sterile 85 
[7,8,9], with any detection of bacteria linked to the mode of delivery [10]; (ii) typically 86 
sterile, with any bacteria detected arising due to co-existent maternal conditions, such as 87 
periodontal disease [10,11], vaginal infection [12], or gestational diabetes [13]; (iii) 88 
universally colonised with low abundant, non-pathogenic bacteria [14]. Although the 89 
existence of a unique microbiome in healthy membranes remains debated [6,14], the 90 
healthy bacterial profile (composition and proportion of bacteria) is suggested to consist 91 
mainly of Escherichia spp. [14,15]. Alternatively, HCA membranes from preterm and term 92 
labour have presented with Ureaplasma spp. in 59% and 60% of cases respectively [2], 93 
suggesting any involvement is independent of gestation. Whilst other studies link HCA and 94 
inflammation with increased bacterial load (measurable quantity of bacteria) [16], with a 95 
positive correlation between the load of Prevotella spp. and HCA severity [17]. Alternatively, 96 
lower bacterial diversity has been implicated in preterm HCA membranes compared to 97 
controls [15], with monomicrobial characteristics in 83% of HCA cases [2]. In contrast, 98 
studies using shotgun and 16S rRNA gene sequencing have reported no distinct bacterial 99 
profiles in HCA membranes [6].  100 
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Careful consideration is required when elucidating the microbiome of fetal membranes due 101 
to low biomass characteristics. It is stated that external bacterial contribution will occur 102 
from the use of commercial kits and reagents, especially in low biomass samples [18]. Thus 103 
comparison of samples to DNA extraction kit negative controls is required. However, within 104 
the placental and fetal membranes this may also originate from contributing vaginal or skin 105 
bacteria during delivery or labour [19,20]. 106 
Changes in inflammatory receptors and proinflammatory cytokines have been linked to 107 
HCA, including a two-fold increase in Toll-like Receptor 2 (TLR2)[21] and Interleukin 8 108 
(IL8)[22], suggesting the involvement of bacteria as pro-inflammatory agents. However, the 109 
increase in cytokines may be indicative of active labour rather than being specific to HCA 110 
[23]. Inflammatory biomarkers are routinely investigated for risk of preterm birth [24] and 111 
clinical chorioamnionitis [25], but not yet applied to monitoring the risk or prediction of 112 
HCA. 113 
Aims and objectives 114 
Given HCA is a leading cause of preterm birth [26], research investigating the aetiology 115 
focused specifically on HCA is important. Although HCA and clinical chorioamnionitis 116 
overlap, the use of an established reproducible diagnostic criteria as a marker of fetal 117 
membrane infection ensure focus on HCA. This study aims to quantify the bacterial load, 118 
bacterial profile and diversity in fetal membranes to explore its relationship with the 119 
inflammatory response in HCA, including histological staging and inflammatory markers. 120 
 121 
 122 
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Methods  123 
Tissue selection and preparation  124 
Samples of placenta and fetal membranes (amnion and chorion) were collected, stored and 125 
phenotyped histologically using the established histological criteria by an independent 126 
clinician. Full criteria are described in Waring et al (2015) [21]. The samples were utilised 127 
following informed consent for current research via a transfer agreement, with prior 128 
approval from Newcastle and North Tyneside 1 Research Ethics Committee (Ref: 129 
10/H0906/71).  130 
Fetal membrane samples were collected from 24 patients. Following histological diagnosis 131 
of HCA, patients were prospectively assigned to spontaneous preterm birth with histological 132 
chorioamnionitis (PTB+HCA, n=12), spontaneous preterm birth without HCA (PTB-HCA, n=6) 133 
and spontaneous term birth without HCA (TB-HCA, n=6). Amnion and chorion were available 134 
for a subset of patients (PTB+HCA=8, PTB-HCA=5, TB-HCA=0). In the remainder, amnion 135 
(PTB+HCA=1, PTB-HCA=0, TB-HCA=0), or chorion only were processed (PTB+HCA=3, PTB-136 
HCA=1, TB-HCA=6). Samples were processed in triplicate and prepared with nine DNA 137 
extraction kit negative controls. Negative controls were processed identical to samples, with 138 
dH2O replacing tissue samples.  139 
HCA was defined by standardised criteria, at maternal stage 2 and above [27]. 140 
Subchorionitis was defined as inflammatory stage one [27]. Labour was defined as the 141 
presence of regular spontaneous uterine contractions with progressive cervical dilation 142 
leading to delivery. Term was defined as a gestational age of >37 weeks, term patients were 143 
excluded if presenting with histologically indicated chorioamnionitis. Preterm samples were 144 
collected from patients delivering with a singleton pregnancy, in spontaneous labour at <34 145 
8 
 
 
weeks gestation, due to the inverse relationship between HCA and gestation [5]. Further 146 
sampling methods are presented in Waring et al (2015) [21]. 147 
Genomic DNA extraction 148 
Total genomic DNA was extracted from samples (n=78) and negative controls (n=9) using 149 
QIAamp Fast DNA Tissue Kit (Qiagen) as per manufacturer protocol. NanoDrop 1000 150 
spectrophotometer (V3.8.1, Thermo Fisher) and agarose gel electrophoresis were used to 151 
assess yield, purity and quality of DNA prior to downstream analysis.  152 
Quantitative PCR  153 
Plasmid standards (16S rRNA gene) were generated using Escherichia coli genomic DNA and 154 
amplified via 27F (5’-AGAGTTTGATCMTGGCTCAG-3’) and 1492R primers (5’-155 
TACGGYTACCTTGTTACGACTT-3’, Eurofins). PCR amplicons were purified (ExoSap-IT PCR 156 
clean up Kit; Thermo Fisher, Cat No:78201.1), before cloning into TOP10 competent E. coli 157 
cells (Thermo Fisher, Cat No:C404010) using PGEM-T Easy Vector System (Promega, Cat 158 
No:A1360). Plasmids were isolated using PureYield Plasmid MiniPrep (Promega, Cat 159 
No:A1223). A ten-fold serial dilution of pooled isolated plasmids was performed to create 160 
standard curves. 161 
Absolute qPCR aimed to determine bacterial load within fetal membrane samples using 162 
BactQuant primers (F=5’-CCTACGGGDGGCWGCA-3’ E. coli 341-356, R=5’-163 
GGACTACHVGGGTMTCTAATC-3’ E. coli 786-806) and probe ((6FAM) 5’-CAGCAGCCGCGGTA-164 
3’ (MGBNFQ) E. coli 518-532; Eurofins)[28]. Reactions contained 1µl sample DNA, 1.8µm 165 
forward and reverse primers, 225nM probe, 0.05µg/µl BSA, 4mM MgCl2, 1% formamide and 166 
1X TaqMan Fast Advanced Master Mix (Thermo Fisher, Cat No:4444557) in a total of 10µl. 167 
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Extracted DNA from samples and standards, plus controls of DNA extraction kit negatives 168 
and no template controls (NTC) were assayed in triplicate using CFX Connect Real Time 169 
System (Biorad, CFX Manager V3.1). BactQuant protocol was used [28], with an optimised 170 
annealing temperature of 55°C.  171 
Expression of inflammatory markers 172 
The expression of TLR signalling pathway components was undertaken by relative qPCR and 173 
has been reported previously [21]. Briefly, genes showing significant change in expression 174 
on signalling arrays were individually validated using qPCR. TaqMan GAPDH was selected as 175 
an endogenous control due to consistent results as a house-keeping gene in the signalling 176 
array study. Each assay was performed in triplicate. Findings indicated the involvement of 177 
TLRs in HCA, initiating this research into bacterial involvement in HCA. 178 
Microbiota analysis 179 
Sequencing of DNA samples and negative controls was performed by NU-OMICs 180 
(Northumbria University, UK) as described previously [29], with the universal 16S rRNA gene 181 
primer specific to the V4 region [30]. A sequencing negative control and ZymoBIOMICS 182 
mock microbial community standard were processed alongside samples.  183 
Package DADA2 1.4 [31] and Bioconductor (Version 2)[32] were used to trim and filter 184 
MiSeq data with a q score of <30, to ensure consistent length and high-quality reads [32]. 185 
Forward and reverse paired strands were merged and clustered into Amplicon Sequence 186 
Variants (ASVs)[33], with clusters differentiated by one nucleotide, for high resolution 187 
bacterial detection [33]. Chimeras were removed using remove BimeraDenovo, before 188 
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assigning taxonomy and constructing a phylogenetic tree using RDP14 reference database 189 
[34]. 190 
Statistical analyses 191 
Patient characteristics were analysed using the package TableOne in R [35]. Outcomes were 192 
assessed between subgroups using Kruskal Wallis and Wilcoxon Rank-Sum, with categorical 193 
data analysed by Pearson’s Chi-Squared or Fisher’s Exact [35]. 194 
For the analysis of bacterial load, copy numbers of 16S rRNA gene/mg of tissue were 195 
calculated and log10 transformed. Comparison between conditions were conducted using 196 
Kruskal Wallis followed by Pairwise Wilcoxon Rank-Sum and visualised with ggplot2 [35]. 197 
The correlation of bacterial load to histological staging or inflammatory marker fold change 198 
was performed using linear regression [36] and Spearman’s Rho Bonferroni, respectively 199 
[35]. 200 
For bacterial abundance, PERMANOVA (GUniFrac) and Shannon Alpha Diversity were 201 
explored using Phyloseq [37]. Shannon Alpha diversity assesses local bacterial composition 202 
in a sample, determining variety and number of bacterial genera [38], with this method 203 
beneficial for low read count and low abundance samples [38]. Whereas beta diversity 204 
matrices (PERMAONVA GUniFrac) compare community level similarity across different 205 
samples and subgroups [39]. Further univariate analysis applied false discovery rate 206 
corrections (FDR). FDR controls for multiple comparisons and allows understanding of type 207 
one errors or false-positive results [39]. Comparison between conditions and the above 208 
findings were performed by Kruskal Wallis and Pairwise Wilcoxon Rank-Sum, before 209 
visualising with ggplot2 [35]. 210 
11 
 
 
Results 211 
Participant characteristics are shown in Table 1. No differences were identified between 212 
participants in the PTB+HCA and PTB-HCA subgroups other than HCA stage (p=<0.001) and 213 
grade (p=0.036). Although the focus of this research was HCA, one patient with 214 
inflammatory diagnosed HCA also presented with clinical signs of chorioamnionitis.  215 
 216 
 217 
 218 
 219 
 220 
 221 
 222 
 223 
 224 
 225 
 226 
 227 
 228 
12 
 
 
Characteristic 
Preterm birth  
with HCA 
(PTB+HCA)  
(n=12) 
Preterm birth 
without HCA 
(PTB-HCA)  
(n=6) 
Term birth 
without HCA 
 (TB-HCA) 
(n=6) 
p. value 
PTB+HCA 
PTB-HCA  
TB-HCA 
p. value 
PTB+HCA 
PTB-HCA 
Gestational age  
(mean (SD)) 
29.6 (2.9) 29.7 (4.0) 40.4 (0.6) 0.001 0.779 
Birthweight  
(mean (SD)) 
1387.0 (504.4) 1736.7 (402.3) 3250.0 (495.6) 0.001 0.291 
Maternal age  
(mean (SD)) 
29.3 (8.0) 27.0 (5.5) 32.2 (6.0) 0.411 0.511 
BMI (mean(SD)) 22.0 (9.2) 22.5 (4.5) 22.3 (2.1) 0.515 0.580 
Smoker 4.0 (33.3) 2.0 (33.3) 0.0 0.329 0.806 
Mode of delivery                                          
……  Spontaneous vaginal 
8.0 (66.7) 5.0 (83.3) - - 1.000 
Caesarean section 4.0 (33.3) 1.0 (16.7) - -  
PPROM 9.0 (75.0) 3.0 (50.0) - - 0.330 
Interval from PPROM to 
labour (mean(SD)) 
7.0 (3.2) 1.7 (0.6) - - 0.051 
Previous preterm birth 5.0 (41.7) 1.0 (16.7) - - 0.600 
Antibiotics 7.0 (58.3) 4.0 (66.7) - - 0.604 
Antenatal 
corticosteroids 
11.0 (91.7) 5.0 (83.3) - - 1.000 
HCA Stage 
 (mean (SD)) 
2.2 (0.4) 1.0 (0.0) - - <0.001 
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HCA Grade 
(mean (SD)) 
1.6 (0.5) 1.0 (0.0) - - 0.036 
Clinical cases of 
chorioamnionitis 
1.0 (8.3) 0 (0.0) - - 0.556 
 229 
Table 1: Sample characteristic data. Assessed between conditions of histological 230 
chorioamnionitis (PTB+HCA), plus preterm (PTB-HCA) and term birth without 231 
chorioamnionitis (TB-HCA). Comparison between all three groups was performed using 232 
Kruskal-Wallis and Pearson’s chi-squared. Characteristics monitored in PTB+HCA and PTB-233 
HCA only using Wilcoxon Rank-Sum and Fisher’s exact test. Significance threshold for 234 
comparisons was p=≤0.05 (bold and italics). Results are displayed as n (%) or mean (SD). 235 
Data unavailable for term subjects (-). 236 
 237 
Bacterial load is increased with HCA  238 
Fetal membranes from participants with PTB+HCA displayed a greater mean bacterial load 239 
than those with PTB-HCA (3.4 log10/mg vs 2.4 log10/mg, p=<0.001). When investigating 240 
individual membranes; significantly greater bacterial load was evident in PTB+HCA amnion 241 
tissues compared to PTB-HCA amnion tissues (3.3 log10/mg vs 2.4 log10/mg, p=0.002; Figure 242 
1A). In chorion tissues, PTB+HCA bacterial loads were also greater compared with PTB-HCA 243 
(3.3 log10/mg vs 2.3 log10/mg, p=0.042) and TB-HCA (3.3 log10/mg vs 2.3 log10/mg, p=0.031). 244 
No difference was found between PTB-HCA and TB-HCA chorion (p=0.937, Figure 1B).  245 
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 246 
Figure 1: Quantitative PCR analysis of bacterial load (A+B) and NGS relative abundance 247 
(C+D). qPCR data displayed by log copy number/mg of sample from amnion (A) or chorion 248 
(B) with histological chorioamnionitis (PTB+HCA), preterm birth without chorioamnionitis 249 
(PTB-HCA) and term birth without HCA (TB-HCA). Significance was determined using Kruskal 250 
Wallis and Pairwise Wilcoxon Rank-Sum to a threshold of p=≤0.05. Relative abundance 251 
variation was further analysed between PTB+HCA, PTB-HCA and TB-HCA in amnion (C) and 252 
chorion (D) using GUniFrac PEMANOVA to a significance of p=≤0.05. Relative abundance 253 
was defined as the abundance of each individual genera relative to total percentage of 254 
bacterial genera. 255 
 256 
 257 
 258 
 259 
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Bacterial load positively correlates with histological staging in HCA  260 
There was a significantly positive correlation between bacterial load and histological staging 261 
of membrane inflammation (p=0.001; Figure 2), with higher bacterial load related to higher 262 
stage of HCA.  263 
 264 
 265 
Figure 2: Linear regression analysis. Analysis between bacterial load (log copy number) and 266 
histological staging of membrane inflammation using linear regression to a threshold of 267 
p=≤0.05.  268 
 269 
Bacterial load is positively correlated with inflammatory gene expression 270 
Bacterial loads in amnion and chorion were significantly correlated to the expression of 271 
some inflammatory markers (Table 2). In the chorion, bacterial load was positively 272 
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correlated with IL8 (p=0.002), LY96 (p=0.003), IRAK2 (p=0.004), TLR2 (p=0.005) and TLR1 273 
(p=0.013). In the amnion, only IL8 was significantly correlated with bacterial load (p=0.050).  274 
 275 
Table 2: Correlation of bacterial load against inflammatory gene fold change. Significant 276 
differences displayed individually by amnion or chorion were determined using Spearman’s 277 
Rank Bonferroni (p=≤ 0.05, bold and italics). 278 
Amnion Chorion 
Inflammatory 
marker 
Spearman’s R
s
 p. value Inflammatory 
marker 
Spearman’s R
s
 p. value 
TLR1 0.346 
 
0.247 TLR1 0.538 0.013 
TLR2 0.489 0.093 TLR2 0.600 0.005 
TLR4 0.363 0.224 TLR4 0.147 0.524 
TLR6 -0.093 0.764 TLR6 0.261 0.252 
SARM1 -0.302 0.315 SARM1 0.117 0.613 
MyD88 0.346 0.247 MyD88 0.061 0.793 
LY96 0.357 0.232 LY96 0.631 0.003 
IL8 0.560 0.050 IL8 0.655 0.002 
IRAK2 0.489 0.093 IRAK2 0.612 0.004 
HMGB1 0.050 0.878 HMGB1 0.284 0.211 
SIGIRR 0.368 0.216 SIGIRR 0.139 0.549 
TIRAP 0.088 0.778 TIRAP 0.234 0.306 
17 
 
 
There is varied range of bacterial genera present irrespective of histological phenotype 279 
The bacterial profile was significantly different between groups of PTB+HCA, PTB-HCA and 280 
TB-HCA in both chorion (R2=0.2, p=0.010), and amnion (R2=0.2, p=0.012; Figure 1C and 1D). 281 
However, no specific genera were statistically significantly different when comparing 282 
between groups. 283 
 284 
Alpha diversity does not differentiate between conditions 285 
PTB+HCA samples had the higher overall bacterial diversity (0.7), with PTB-HCA (1.0) and TB-286 
HCA lower (1.1), yet no difference between groups (p=0.220). When analysing by tissue 287 
type, although diversity was highest in both PTB+HCA amnion and chorion the differences 288 
across conditions were not statistically significant (Figure 3).  289 
 290 
 291 
Figure 3: Alpha diversity analysis. Relative abundance sequencing data analysed by 292 
Shannon alpha diversity between amnion (A) and chorion membranes (B) from preterm 293 
birth samples with chorioamnionitis (PTB+HCA), preterm birth without chorioamnionitis 294 
(PTB-HCA) and term birth without chorioamnionitis (TB-HCA) to a threshold of p=≤0.05. 295 
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Non-HCA samples and negative controls differ in bacterial profiles and specific genera, but 296 
not bacterial load 297 
Sequencing and qPCR results from preterm and term patients without HCA were compared 298 
to negative controls to investigate genuine microbiota detection from non-HCA fetal 299 
membranes. The overall bacterial profiles were significantly different between non-HCA 300 
samples and negative controls (r2=0.2, p=<0.001; Figure 4A). Further significance was 301 
detected between specific genera. Dorea was detected in negative controls (average read 302 
number=163.1), but not detected in non-HCA samples (p=0.001, FDR=0.027). The mean 303 
abundance from Pseudomonas was significantly greater in negative controls (91.7) 304 
compared to PTB-HCA (4.8) and TB-HCA samples (2.8; p=0.002, FDR=0.030). Escherichia was 305 
significantly reduced in TB-HCA (45.5), compared to similar levels from PTB-HCA (2295.2) 306 
and negative controls (2237.2; p=<0.001, FDR=<0.001). There was no variation in 307 
Lactobacillus (p=0.050, FDR=0.303), Ureaplasma (p=0.073, FDR=0.308) or Prevotella 308 
(p=0.608, FDR=0.730). 309 
No significant difference was detected when comparing bacterial loads of non-HCA samples 310 
to negative controls (2.4 log10, p=0.9277; Figure 4B). For clarification, no bacterial loads 311 
were detected from NTCs for all qPCR experiments. 312 
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 313 
Figure 4: Negative control comparison; Relative abundance (A) and qPCR bacterial load 314 
(B). Analysis between kit negative controls (Negative Control) and non-HCA samples of 315 
preterm (PTB-HCA) and term fetal membranes without chorioamnionitis (TB-HCA) were 316 
compared. Relative abundance was analysed using GUniFrac PERMANOVA to a significance 317 
of p=≤0.05. qPCR bacterial load (log copy number/mg) results displayed by comparison 318 
between PTB-HCA, TB-HCA and Negative Control. Significance was determined using Kruskal 319 
Wallis to a threshold of p=≤0.05.  320 
 321 
 322 
 323 
 324 
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Discussion  325 
Main findings 326 
Findings indicate that a greater bacterial load is associated with HCA and a greater bacterial 327 
load is positively correlated with greater histological staging and inflammatory markers. This 328 
supports the suggestion that bacteria act as inflammatory agents in a dose dependent 329 
manner in HCA. 330 
Interpretation 331 
The key finding of this study is that inflammation in the fetal membranes is associated 332 
with presence of bacterial infection and increased bacterial load. Previous research 333 
supports the theory that bacterial presence is linked to HCA [19,20], with 97% of HCA cases 334 
presenting with bacterial colonisation [40], leading to microbial associated inflammation of 335 
the amnion [40]. Bacterial loads of up to 5.2 log10 copies/µl have also been detected in fetal 336 
membranes with HCA [16], consistent with our findings. In contrast, Romero et al (2014)[41] 337 
detected bacteria in 11% of amniotic fluid samples with PTB and intra-amniotic 338 
inflammation, compared to 26% with a sterile inflammatory response [41]. Studies have 339 
linked HCA to bacterial loads of specific genera, including Prevotella [17] and Ureaplasma 340 
[40]. The expansion of Ureaplasma in HCA was supported here yet did not reach 341 
significance. Although inflammation has not been attributed to specific organisms here, 342 
investigation of the species-specific bacterial load may play a role in this multifactorial 343 
inflammatory condition. As the likely passage of bacteria is ascending, lower bacterial load 344 
would be expected in the chorion. Although consistent bacterial load was present across 345 
membranes with HCA here, the inflammatory response may differ across membranes 346 
impacting clinical relevance and requiring further investigation.  347 
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Findings show that bacterial load is positively correlated with HCA severity in a dose 348 
dependent manner. This observation is supported across multiple methodologies and tissue 349 
types [19,42,43]. Research on chorioamniotic membranes has suggested that as HCA 350 
severity increased, so did bacterial load [19]. Bacteria were detected in 87% of membranes 351 
with stage three HCA, compared to 33%, 40% and 60% with stage zero, one and two HCA, 352 
respectively [19]. In amniotic fluid, bacterial load was 106 copies/ml with stage three HCA, 353 
compared to 103 copies/ml in stages zero, one and two [42]. However, the link between 354 
bacterial load and inflammation in HCA has been questioned, with the suggestion that any 355 
increase in bacterial load or inflammation is due to active labour rather than specific to HCA 356 
[23]. In this study all patients recruited were in spontaneous active labour, limiting variation 357 
and controlling for vaginal contamination, and the relationship between histological grading 358 
and bacterial load remained consistent. Although the focus here was on preterm patients, 359 
studies addressing HCA at term are required.  360 
Data suggests that bacterial load correlates to inflammation via activation of the TLR 361 
signalling pathway. We have previously reported an increase in gene expression of TLR1 362 
and TLR2 in HCA in the same samples, with a correlation between the increase in TLR gene 363 
expression and HCA stage in both amnion and chorion [21]. Correlation between HCA 364 
bacterial load with TLR1/2 suggests that the number of gram-negative bacteria in the fetal 365 
membranes may be important in the development of HCA, as the TLR1/2 heterodimer 366 
recognises lipopeptides from gram negative bacteria. Although a trend was present , we 367 
were unable to identify significant differences in specific genera (including gram-negative 368 
bacteria) between groups. IL8 was the only inflammatory marker that correlated with 369 
bacterial load in both membranes. The IL8 ligand has been detected in greater 370 
concentrations from HCA patients compared to without HCA, as supported by Kacerovsky et 371 
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al (2009) [44]. IL8 levels have previously been used to predict HCA staging in amniotic fluid, 372 
with high specificity [45]. Alternatively, danger signals including HMGB1 also activate the 373 
TLR/MyD88 dependent pathway [46], known as the sterile inflammatory response theory 374 
[41]. However, our work suggests that bacterial load is the key driver to inflammation in the 375 
fetal membranes studied here. 376 
Findings show that non-HCA samples and negative controls differ in few specific bacterial 377 
genera but display no difference in bacterial load. Previous studies have also detected 378 
genera originating mainly from negative controls, including Dorea and Pseudomonas when 379 
establishing bacterial profiles of placental samples [18,47]. These genera are suggested to 380 
be contaminants in low biomass research [18,47], thus findings indicating clinical relevance 381 
of these bacteria are to be carefully analysed and ensure that correct methodology and 382 
negative controls have been included to avoid misinterpretation. 383 
Research and clinical implications 384 
Conflicting literature highlights the difficulty of reaching a conclusion on the fetal membrane 385 
microbiome in HCA [2,16,23,46]. Although a linear relationship between bacterial load and 386 
inflammation was detected here, the threshold overall bacterial load required to activate 387 
the inflammatory response warrants further study. Investigating selected inflammatory 388 
markers as potential biomarkers for HCA, including TLR signalling mediators, may be 389 
important, including a focus on LY96 (MD2) which links cell surface TLR to bacterial LPS. 390 
PPROM was the most prevalent cause of PTB, occurring in 75% of HCA and 50% of PTB 391 
patients, thus it may be of interest to investigate the variation in HCA between PPROM and 392 
sPTB. Additional research may also aim to understand the origin of bacteria using multiple 393 
body site analysis 394 
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Strengths and limitations  395 
The absence of a known healthy fetal membrane microbiome complicates the ability to 396 
determine a microbiome linked to HCA. Thus, fetal membranes without chorioamnionitis 397 
from preterm and term labour are required for within study comparisons, as incorporated 398 
into this study. The histological threshold for HCA was set at stage two inflammatory 399 
response. However, only one stage three sample was available from the HCA subgroup, 400 
limiting conclusions at this level. Excluding stage one subchorionitis ensures specificity to 401 
HCA rather than subclinical chorioamnionitis, and is an established reproducible diagnostic 402 
criterion for HCA. Other studies may have included stage one, leading to different 403 
conclusions as to the role of infection and inflammation in HCA.  404 
The fetal membrane is a low biomass sample [45,47], which increases the risk of 405 
contamination [48]. To minimise this, negative controls were included and compared to 406 
samples and all samples displayed progressive labour, limiting variation. A 24-patient 407 
sample set from one tertiary unit was utilised increasing consistency of sample handling. A 408 
larger sample set would have strengthened findings to cover heterogeneity of maternal and 409 
fetal response, though the low incidence of early preterm birth and HCA is a recognised 410 
challenge in this field of research. For a subset of patients only amnion or chorion were 411 
available, which could bias results and is a known limitation of human tissue collection. 412 
Bacterial origin cannot be determined as only fetal membrane samples were analysed. The 413 
inclusion of vaginal, oral, skin and blood samples would allow greater understanding of the 414 
source of bacteria and allow further investigation into the link between reproductive, 415 
placental and fetal membrane health [49]. 416 
Conclusions 417 
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The data indicates that inflammation of the fetal membranes is associated with infection 418 
and increased bacterial load in a dose dependent relationship, rather than specific bacterial 419 
profiles. Bacterial load is positively correlated to HCA severity and activation of the TLR 420 
signalling pathway. Further research investigating the bacterial threshold level required to 421 
generate an inflammatory response leading to HCA requires attention.  422 
 423 
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 426 
 427 
 428 
 429 
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 431 
 432 
 433 
 434 
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